The Rx Savings Finder marketplace has already saved patients almost $70 millionRead more...
Hedge fund says Board did not act "in good faith" when hiring Yahoo CEO
If Yahoo CEO Scott Thompson had any hopes that the story about his academic record was just going to fade away, he could not have been more wrong. In fact, it seems like his troubles arejust beginning.
Third Point CEO Dan Loeb is now stepping up his attacks on Thompson, sending the Yahoo Board of Directors a second letter in less than a week demanding an investigation into an alleged discrepancies on Thompson’s resume.
The first letter, which Loeb sent late last week, accused Thompson, and Search Committee chairperson Patti Hart, of falsifying their academic records.
Thompson apparently listed a bachelor’s degree in computer science from Stonehill College on his resume, a degree that the school didn’t even offer until four years after Thompson had already graduated.
While Loeb did not lay out any specific demands in his first letter, he strongly implied that, should the allegations be true, both Thompson and Hart should be fired.
Yahoo did not act on his request, so Loeb has now sent the Yahoo board another letter, this time citing a Delaware law that allows shareholders to scrutinize a company’s books if there is proper cause.
Loeb wrote that he is demanding the information to investigate if there was any wrongdoing committed:
- “in connection with the hiring of Scott Thompson as the Chief Executive Officer of the Company and his appointment to the Board”
- “in connection with the appointment of Peter Liguori, John Hayes, Thomas McInerney, Maynard Webb, Jr. and Fred Amoroso to the Yahoo! board rather than the nominees proposed by Third Point”
- “in connection with the statements by Yahoo! on the afternoon of May 3 that the false filings about Mr. Thompson’s educational background were ‘inadvertent’”
- “To determine whether Scott Thompson, Patti Hart, Peter Liguori, John Hayes, Maynard Webb, Jr., Fred Amoroso, and Thomas McInerney are suitable to serve as directors of Yahoo!”
- “To facilitate communications with other stockholders concerning the matters identified in paragraphs 1 through 4 above, in connection with a proxy contest to replace the current board of directors with nominees proposed by Third Point.”
Among the documents that Loeb is insisting Yahoo provide him are copies of any material supplied by Thompson to the Board, all communications between Thompson and the search committee, and any background checks done of Thompson.
Loeb writes that he believes the documents will prove that, not only did Thompson lie on his resume, but that the Yahoo Board knew about it when they hired him. He even goes so far as to accuse the Board of purposely rejecting Third Point’s nominees in favor of Thompson, though he does not specify why he believe they would do this.
“We believe the decision to reject Third Point’s nominees was pretextual and not made in good faith. As shown above, it appears the Nominating Committee would rather recommend an individual to the Yahoo! Board who submitted a false resume than the highly qualified individuals nominated by Third Point. The failure to detect the easily-discoverable inaccuracies in Mr. Thompson’s resume creates significant doubt as to the thoroughness of the entire board nomination process and, ultimately, the suitability of Messrs. Liguori, Hayes, McInerney, Webb and Amoroso to serve on the Board.”
Thompson, the former President of PayPal, was appointed CEO of Yahoo in January. This latest scandal is the latest episode in a short, but rocky, tenure that has seen massive layoffs and a patent lawsuit against Facebook.
It is unclear what Yahoo’s next course of action is, but it seems unlikely they will give in to Loeb’s demands without a fight. The fight between Third Point and Yahoo might very well develop into a protracted legal battle over access to documents.
Yahoo did not return our request for comment
(Image source: ibnlive.in.com)
Support VatorNews by Donating
Read more from our "Trends and news" series
The company works with pharma and biotech to help with drug developmentRead more...
The company plans to open clinics in New Jersey, Connecticut, and Maryland next yearRead more...